1. Home
  2. REPL vs TK Comparison

REPL vs TK Comparison

Compare REPL & TK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Replimune Group Inc.

REPL

Replimune Group Inc.

N/A

Current Price

$12.88

Market Cap

1.4B

Sector

Health Care

ML Signal

N/A

Logo Teekay Corporation

TK

Teekay Corporation

N/A

Current Price

$14.75

Market Cap

1.2B

ML Signal

N/A

Company Overview

Basic Information
Metric
REPL
TK
Founded
2015
1973
Country
United States
Bermuda
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Marine Transportation
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.2B
IPO Year
2018
1995

Fundamental Metrics

Financial Performance
Metric
REPL
TK
Price
$12.88
$14.75
Analyst Decision
Hold
Analyst Count
9
0
Target Price
$5.67
N/A
AVG Volume (30 Days)
2.2M
476.5K
Earning Date
05-21-2026
05-13-2026
Dividend Yield
N/A
15.21%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$13.43
Revenue Growth
N/A
N/A
52 Week Low
$1.50
$7.80
52 Week High
$16.33
$14.39

Technical Indicators

Market Signals
Indicator
REPL
TK
Relative Strength Index (RSI) 42.98 69.28
Support Level $6.81 $12.11
Resistance Level $16.02 N/A
Average True Range (ATR) 0.71 0.44
MACD -0.45 0.06
Stochastic Oscillator 14.89 96.34

Price Performance

Historical Comparison
REPL
TK

About REPL Replimune Group Inc.

Replimune Group Inc is a clinical-stage biotechnology company committed to applying its expertise in the field of oncolytic immunotherapy to transform the lives of cancer patients through novel oncolytic immunotherapies. Its proprietary oncolytic immunotherapy product candidates are designed and intended to maximally activate the immune system against cancer. Oncolytic immunotherapy is an emerging drug class. The proprietary RPx platform is based on a novel, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added that are intended to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. It operates in single segment of developing oncolytic immunotherapies for the treatment of cancer.

About TK Teekay Corporation

Teekay Corp Ltd provides international crude oil marine transportation and other marine services. It also offers offshore oil production, storage, and offloading services, under long-term, fixed-rate contracts. The company has two primary lines of business: Marine services and tankers. It manages these businesses for the benefit of all stakeholders. The company serves energy and utility companies, oil traders, large oil and LNG consumers, petroleum product producers, government agencies, and various other entities that depend upon marine transportation.

Share on Social Networks: